Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 938,944 | 631,908 | 1,087,720 | 929,026 | 950,052 |
| Marketable Securities | 16,100 | 13,200 | 12,100 | 58,200 | 48,500 |
| Receivables | 28,901 | 27,743 | 23,785 | 26,956 | 24,901 |
| Other current assets | 865,592 | 847,390 | 719,638 | 787,957 | 770,742 |
| TOTAL | $1,849,537 | $1,520,241 | $1,843,243 | $1,802,139 | $1,794,195 |
| Non-Current Assets | |||||
| PPE Net | 15,763,670 | 15,134,290 | 15,032,010 | 15,127,160 | 14,968,070 |
| Investments And Advances | 722,850 | 658,343 | 696,291 | 1,259,884 | 1,237,184 |
| Intangibles | 924,634 | 924,634 | 0 | 0 | 0 |
| Other Non-Current Assets | 86,586 | 85,493 | 36,709 | 33,536 | 42,796 |
| TOTAL | $17,497,740 | $16,802,760 | $15,765,010 | $16,420,580 | $16,248,050 |
| Total Assets | $19,347,280 | $18,323,000 | $17,608,260 | $18,222,710 | $18,042,240 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 380,000 | 999,436 | 998,605 | 997,773 | 996,942 |
| Accounts payable and accrued liabilities | 118,637 | 118,406 | 146,426 | 89,181 | 101,204 |
| Accrued Expenses | 29,044 | 85,609 | 19,221 | 98,062 | 38,412 |
| Other current liabilities | 3,121 | 3,075 | 18,600 | 68,600 | 31,200 |
| TOTAL | $530,802 | $1,206,526 | $1,182,852 | $1,253,616 | $1,167,758 |
| Non-Current Liabilities | |||||
| Long Term Debt | 8,565,735 | 7,003,063 | 6,618,847 | 6,614,653 | 6,610,437 |
| Other Non-Current Liabilities | 473,888 | 550,012 | -177,184 | -114,057 | -256,791 |
| TOTAL | $9,195,617 | $7,613,534 | $6,636,747 | $6,626,733 | $6,616,017 |
| Total Liabilities | $9,726,419 | $8,820,060 | $7,819,599 | $7,880,349 | $7,783,775 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 577,238 | 583,174 | 562,240 | 576,453 | 589,183 |
| Common Shares | 107 | 107 | 106 | 108 | 108 |
| Retained earnings | 2,304,314 | 2,222,750 | 2,480,664 | 2,845,653 | 2,764,685 |
| Other shareholders' equity | 3,206,902 | 3,155,418 | 3,100,356 | 3,396,127 | 3,388,935 |
| TOTAL | $9,620,861 | $9,502,940 | $9,788,657 | $10,342,370 | $10,258,470 |
| Total Liabilities And Equity | $19,347,280 | $18,323,000 | $17,608,256 | $18,222,719 | $18,042,245 |